FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114847308> ?p ?o ?g. }

• W2114847308 endingPage "1820" @default.
• W2114847308 startingPage "1815" @default.
• W2114847308 abstract "The concept of chronic kidney disease-mineral bone disorder (CKD-MBD) does not appear to fulfil the requirements for a syndrome at first glance, but its definition has brought some clear-cut benefits for clinicians and patients, including wider and more complex diagnostic and therapeutic approaches to the management of this challenging set of issues. Admittedly, not all components of CKD-MBD are present in all patients at all times, but these are highly interrelated, involving mineral and bone laboratory abnormalities, clinical and histological bone disease and finally, cardiovascular disease. The presence of typical biological bone ossification processes in an ectopic anatomical location in CKD has helped to define the existence of an unprecedented bone-vascular relationship, extending its interest even to other medical specialities. For now, we believe that CKD-MBD does not reach full criteria to be defined as a syndrome. However, this novel concept has clearly influenced current clinical guidelines. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) guidelines in 2003 for instance recommended that calcium-based phosphate binders should be avoided to treat hyperphosphataemia in the presence of cardiovascular calcifications. In 2009, the KDIGO and other guidelines reinforced and extended this recommendation by stating that it is reasonable to choose oral phosphate binder therapy by taking into consideration other components of CKD-MBD. Similarly, it is also considered reasonable to use information on vascular/valvular calcification to guide the management of CKD-MBD. Our current assumption as a working group 'CKD-MBD' is that CKD-MBD has the potential to be defined a true syndrome, such as a constellation of concurrent signs and symptoms that suggest a common underlying mechanism for these components as opposed to the term disease. The term 'syndrome' also implies that in any patient at risk due to the presence of one or a few components of the entire syndrome, the screening for additional components is highly recommended. However, it has not currently been demonstrated that there is an additive predictive value, which can be derived from identifying individual components. Despite all we have learned about this putative syndrome, we have been left with only a hypothetical framework about how to treat patients. So while we agree that the concept of CKD-MBD has influenced, and continues to influence, our current clinical hypotheses, definitive proof of a benefit of interventions in CKD-MBD is still lacking and a global-multiple therapeutic approach to treat simultaneously several components of CKD-MBD should be tested by well-designed new randomized controlled trials." @default.
• W2114847308 created "2016-06-24" @default.
• W2114847308 creator A5004405514 @default.
• W2114847308 creator A5018320268 @default.
• W2114847308 creator A5027966081 @default.
• W2114847308 creator A5031521563 @default.
• W2114847308 creator A5040355091 @default.
• W2114847308 creator A5049079690 @default.
• W2114847308 creator A5058069521 @default.
• W2114847308 creator A5071660720 @default.
• W2114847308 creator A5080009012 @default.
• W2114847308 date "2014-02-09" @default.
• W2114847308 modified "2023-10-06" @default.
• W2114847308 title "Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?" @default.
• W2114847308 cites W1947711157 @default.
• W2114847308 cites W2034953297 @default.
• W2114847308 cites W2036812212 @default.
• W2114847308 cites W2053932423 @default.
• W2114847308 cites W2078807483 @default.
• W2114847308 cites W2102109777 @default.
• W2114847308 cites W2102420952 @default.
• W2114847308 cites W2109064733 @default.
• W2114847308 cites W2114902110 @default.
• W2114847308 cites W2120862552 @default.
• W2114847308 cites W2122037712 @default.
• W2114847308 cites W2123775770 @default.
• W2114847308 cites W2128375129 @default.
• W2114847308 cites W2131048848 @default.
• W2114847308 cites W2136722090 @default.
• W2114847308 cites W2138829372 @default.
• W2114847308 cites W2139184062 @default.
• W2114847308 cites W2145582432 @default.
• W2114847308 cites W2145632027 @default.
• W2114847308 cites W2146806054 @default.
• W2114847308 cites W2150640826 @default.
• W2114847308 cites W2160742303 @default.
• W2114847308 cites W2172159264 @default.
• W2114847308 doi "https://doi.org/10.1093/ndt/gft514" @default.
• W2114847308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24516228" @default.
• W2114847308 hasPublicationYear "2014" @default.
• W2114847308 type Work @default.
• W2114847308 sameAs 2114847308 @default.
• W2114847308 citedByCount "93" @default.
• W2114847308 countsByYear W21148473082014 @default.
• W2114847308 countsByYear W21148473082015 @default.
• W2114847308 countsByYear W21148473082016 @default.
• W2114847308 countsByYear W21148473082017 @default.
• W2114847308 countsByYear W21148473082018 @default.
• W2114847308 countsByYear W21148473082019 @default.
• W2114847308 countsByYear W21148473082020 @default.
• W2114847308 countsByYear W21148473082021 @default.
• W2114847308 countsByYear W21148473082022 @default.
• W2114847308 countsByYear W21148473082023 @default.
• W2114847308 crossrefType "journal-article" @default.
• W2114847308 hasAuthorship W2114847308A5004405514 @default.
• W2114847308 hasAuthorship W2114847308A5018320268 @default.
• W2114847308 hasAuthorship W2114847308A5027966081 @default.
• W2114847308 hasAuthorship W2114847308A5031521563 @default.
• W2114847308 hasAuthorship W2114847308A5040355091 @default.
• W2114847308 hasAuthorship W2114847308A5049079690 @default.
• W2114847308 hasAuthorship W2114847308A5058069521 @default.
• W2114847308 hasAuthorship W2114847308A5071660720 @default.
• W2114847308 hasAuthorship W2114847308A5080009012 @default.
• W2114847308 hasBestOaLocation W21148473081 @default.
• W2114847308 hasConcept C126322002 @default.
• W2114847308 hasConcept C177713679 @default.
• W2114847308 hasConcept C2776556354 @default.
• W2114847308 hasConcept C2776699218 @default.
• W2114847308 hasConcept C2778653478 @default.
• W2114847308 hasConcept C2779134260 @default.
• W2114847308 hasConcept C2780309369 @default.
• W2114847308 hasConcept C2780814755 @default.
• W2114847308 hasConcept C71924100 @default.
• W2114847308 hasConceptScore W2114847308C126322002 @default.
• W2114847308 hasConceptScore W2114847308C177713679 @default.
• W2114847308 hasConceptScore W2114847308C2776556354 @default.
• W2114847308 hasConceptScore W2114847308C2776699218 @default.
• W2114847308 hasConceptScore W2114847308C2778653478 @default.
• W2114847308 hasConceptScore W2114847308C2779134260 @default.
• W2114847308 hasConceptScore W2114847308C2780309369 @default.
• W2114847308 hasConceptScore W2114847308C2780814755 @default.
• W2114847308 hasConceptScore W2114847308C71924100 @default.
• W2114847308 hasIssue "10" @default.
• W2114847308 hasLocation W21148473081 @default.
• W2114847308 hasLocation W21148473082 @default.
• W2114847308 hasLocation W21148473083 @default.
• W2114847308 hasOpenAccess W2114847308 @default.
• W2114847308 hasPrimaryLocation W21148473081 @default.
• W2114847308 hasRelatedWork W2012225890 @default.
• W2114847308 hasRelatedWork W2045872757 @default.
• W2114847308 hasRelatedWork W2403292263 @default.
• W2114847308 hasRelatedWork W2407498151 @default.
• W2114847308 hasRelatedWork W2421778743 @default.
• W2114847308 hasRelatedWork W2484766279 @default.
• W2114847308 hasRelatedWork W2586731455 @default.
• W2114847308 hasRelatedWork W2902503131 @default.
• W2114847308 hasRelatedWork W3029384903 @default.
• W2114847308 hasRelatedWork W4302068949 @default.

• next